#ai-drug-discovery tag

AI drug startup Insilico Medicine launches an AI 'gym' to help models like GPT and Qwen be good at science | Fortune

Generalist models "fail miserably" at the benchmarks used to measure how AI performs scientific tasks, Alex Zhavoronkov, Insilico's founder and CEO, told Fortune. " You test it five times at the same task, and you can see that it's so far from state of the art...It's basically worse than random. It's complete garbage." Far better are specialist AI models that are trained directly on chemistry or biology data.

Science

#startup-funding

New York City

#NYCtech Week in Review: 1/11/26 - 1/17/26

NYC startups secured major funding this week, led by Rain ($250M), Proxima ($80M), WithCoverage ($42M), Flip CX ($20M), GiveCard ($8.9M), Noise Labs ($7.1M).

8 months ago

NYC startup

#NYCtech Week in Review: 5/4/25 - 5/10/25

Several NYC startups secured significant funding in recent news, indicating a robust ecosystem.

Wonder raised $600M, leading the funding round among several successful startups.

New York City

#NYCtech Week in Review: 1/11/26 - 1/17/26

NYC startup

8 months ago

#NYCtech Week in Review: 5/4/25 - 5/10/25

Several NYC startups secured significant funding in recent news, indicating a robust ecosystem.

Wonder raised $600M, leading the funding round among several successful startups.

Medicine

From OpenAI's offices to a deal with Eli Lilly - how Chai Discovery became one of the flashiest names in AI drug development | TechCrunch

Startup companies

OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation | TechCrunch

Medicine

From OpenAI's offices to a deal with Eli Lilly - how Chai Discovery became one of the flashiest names in AI drug development | TechCrunch

Startup companies

OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation | TechCrunch

The AlleyWatch Startup Daily Funding Report: 1/14/2026

Proxima raised $80M Seed for AI-driven proximity-based drug discovery; WithCoverage raised $42M Series B for risk management and insurance brokerage for fast-growing businesses.

#antibiotic-resistance

Artificial intelligence

What will define 2026, according to leaders in space, healthcare, and AI

Medicine

MIT drug hunters are using AI to design completely new antibiotics

Artificial intelligence

What will define 2026, according to leaders in space, healthcare, and AI

more#antibiotic-resistance

Medicine

MIT drug hunters are using AI to design completely new antibiotics

Medicine

Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz | TechCrunch

Generative AI trained on DNA, RNA, and protein sequences accelerates drug discovery, enabling faster antibody design, protein optimization, and target identification while attracting investor funding.

Medicine

from24/7 Wall St.

Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma's Future

Eli Lilly and Nvidia will invest up to $1 billion in a five-year AI co-innovation lab to accelerate drug discovery using machine learning and supercomputing.

New York City